Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Haematologica|December 2, 2016
Eltrombopag, a potent stimulator of megakaryopoiesisHana Raslova, William Vainchenker, Isabelle Plo
F1000Research|May 3, 2016
Recent advances in understanding myelofibrosis and essential thrombocythemiaWilliam Vainchenker, Stefan N Constantinescu, Isabelle Plo
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2023
Optimizing IFN Alpha Therapy against Myeloproliferative NeoplasmsGurvan Hermange, Paul-Henry Cournède, Isabelle Plo
Molecular & Cellular Oncology|June 17, 2016
ATG2B and GSKIP: 2 new genes predisposing to myeloid malignanciesIsabelle Plo, Christine Bellanné-Chantelot, William Vainchenker
Medecine Sciences : M/S|February 27, 2024
[Natural history of myeloproliferative neoplasms by a phylogenetic tree-based approach]Jackson Josil, Eva Thuillier, Laetitia Chambrun, et al.
Mathematical Medicine and Biology : a Journal of the IMA|June 14, 2024
Mathematical modelling, selection and hierarchical inference to determine the minimal dose in IFNα therapy against myeloproliferative neoplasmsGurvan Hermange, William Vainchenker, Isabelle Plo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapyFlorence Pasquier, Xenia Cabagnols, Lise Secardin, et al.
Blood Cancer Journal|May 12, 2026
Impaired iron balance and erythrocytosis: a complex relationshipBenoît Gendrot, Carole Peyssonnaux, Isabelle Plo, et al.
Oncoimmunology|September 14, 2020
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosisOliver Kepp, Peng Liu, Liwei Zhao, et al.
Bulletin Du Cancer|August 7, 2016
[Not Available]Matthieu Mosca, Gaëlle Vertenoeil, Katte Rao Toppaldoddi, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Haematologica|December 2, 2016
Eltrombopag, a potent stimulator of megakaryopoiesisHana Raslova, William Vainchenker, Isabelle Plo
F1000Research|May 3, 2016
Recent advances in understanding myelofibrosis and essential thrombocythemiaWilliam Vainchenker, Stefan N Constantinescu, Isabelle Plo
The Journal of Pharmacology and Experimental Therapeutics|June 30, 2023
Optimizing IFN Alpha Therapy against Myeloproliferative NeoplasmsGurvan Hermange, Paul-Henry Cournède, Isabelle Plo
Molecular & Cellular Oncology|June 17, 2016
ATG2B and GSKIP: 2 new genes predisposing to myeloid malignanciesIsabelle Plo, Christine Bellanné-Chantelot, William Vainchenker
Medecine Sciences : M/S|February 27, 2024
[Natural history of myeloproliferative neoplasms by a phylogenetic tree-based approach]Jackson Josil, Eva Thuillier, Laetitia Chambrun, et al.
Mathematical Medicine and Biology : a Journal of the IMA|June 14, 2024
Mathematical modelling, selection and hierarchical inference to determine the minimal dose in IFNα therapy against myeloproliferative neoplasmsGurvan Hermange, William Vainchenker, Isabelle Plo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapyFlorence Pasquier, Xenia Cabagnols, Lise Secardin, et al.
Blood Cancer Journal|May 12, 2026
Impaired iron balance and erythrocytosis: a complex relationshipBenoît Gendrot, Carole Peyssonnaux, Isabelle Plo, et al.
Oncoimmunology|September 14, 2020
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosisOliver Kepp, Peng Liu, Liwei Zhao, et al.
Bulletin Du Cancer|August 7, 2016
[Not Available]Matthieu Mosca, Gaëlle Vertenoeil, Katte Rao Toppaldoddi, et al.
Pageof 13